A Novel Fusicoccin Derivative Preferentially Targets Hypoxic Tumor Cells and Inhibits Tumor Growth in XenograftsKoshi Kawakami, Yoshio Honma, Junko Ohkanda et al.|Anti-Cancer Agents in Medicinal Chemistry|2012Cited by 36
Semisynthesis and biological evaluation of a cotylenin A mimic derived from fusicoccin ATakatsugu Inoue, Nobuo Kato, Yusuke Higuchi et al.|Bioorganic & Medicinal Chemistry Letters|2018Cited by 23